NEDD4L and pancreatic neoplasm: Further, NEDD4L was found to inhibit ULK1- and ASCT2-mediated mitophagy whereby suppressing adequate fuel supplementation via mitochondrial metabolism, leading to inducing cell death and inhibiting tumor growth in pancreatic cancer cells (Lee et al. 2020a).